Liver Illness and Psoriatic Patients

Marco Fiore, Sebastiano Leone, Alberto Enrico Maraolo, Emilio Berti, Giovanni Damiani

Research output: Contribution to journalReview article

Abstract

Psoriasis is a chronic inflammatory disease of the skin affecting approximately 2% of the world's population. Systemic treatments, including methotrexate and cyclosporin, are associated with potential hepatotoxicity, due to either direct liver damage or immunosuppression or both immunomediated and a direct liver injury; therefore, treatment of patients with psoriasis poses a therapeutic challenge. The aim of this minireview is to help clinicians in the management of psoriatic patients who develop signs of liver dysfunction. To find relevant articles, a comprehensive search was performed on PubMed, EMBASE, and Cochrane with appropriate combinations of the following keywords being considered: Viral hepatitis, nonalcoholic fatty liver disease, psoriasis, hepatotoxicity, drug toxicity, cholestasis, and autoimmune liver diseases.

Original languageEnglish
Article number3140983
JournalBioMed Research International
Volume2018
DOIs
Publication statusPublished - Jan 1 2018

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Fingerprint Dive into the research topics of 'Liver Illness and Psoriatic Patients'. Together they form a unique fingerprint.

  • Cite this

    Fiore, M., Leone, S., Maraolo, A. E., Berti, E., & Damiani, G. (2018). Liver Illness and Psoriatic Patients. BioMed Research International, 2018, [3140983]. https://doi.org/10.1155/2018/3140983